Vimarsana
Biggest News Aggregation in the World

Page 2 - Fixed Dose Combinations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fixed Dose Combinations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fixed Dose Combinations Today - Breaking & Trending Today

Govt bans 14 fixed dose combination drugs including Nimesulide and Paracetamol, citing health risk; check full list here - Vimarsana News

Govt bans 14 fixed dose combination drugs including Nimesulide and Paracetamol, citing health risk; check full list here

Centre has banned 14 FDC drugs due to ‘no therapeutic justification’ and potential risk to patients, including Nimesulide and Paracetamol dispersible tablets and Chlopheniramine Maleate and Codeine syrup. The Health Ministry issued the notification based on recommendations from an expert committee.

Govt bans 14 cocktail drugs citing risk to people; check the list here - Vimarsana News

Govt bans 14 cocktail drugs citing risk to people; check the list here

An expert committee has said there is

States licensed 36 banned drugs in 2 years, 9 in Himachal Pradesh: Govt admits in Lok Sabha - Vimarsana News

States licensed 36 banned drugs in 2 years, 9 in Himachal Pradesh: Govt admits in Lok Sabha

Close on the heels of Sonepat-based Maiden Pharma’s cough and cold syrups attracting WHO’s global medical alert over links to the deaths of more than 66 Gambian children, the Government on Tuesday informed the Rajya Sabha that 36 banned drugs were licensed by different state drug regulat

Glenmark launches Sitagliptin and its fixed dose combinations in India - Vimarsana News

Glenmark launches Sitagliptin and its fixed dose combinations in India

Sitagliptin is considered as the gold standard molecule in DPP4 inhibitor therapy.

Glenmark launches Sitagliptin for adults with Type 2 diabetes in India - Vimarsana News

Glenmark launches Sitagliptin for adults with Type 2 diabetes in India

The company has introduced 8 different combinations of sitagliptin-based drugs under the brand name SITAZIT